Atomo Diagnostics Limited announce it has secured a purchase order from UK based diagnostics company Newfoundland Diagnostics Limited (Newfoundland), worth approximately AUD 900,000. The order is for immediate supply of Atomo's product to Newfoundland, subject to updating Atomo's existing HIV Self-Test CE certificate to include the relevant distributor information and branding. Newfoundland is an emerging leader in the growing European diagnostic self-test market that has arisen out of the COVID pandemic and has established extensive distribution networks in Europe across public health, pharmacy and retail channels.

Atomo and Newfoundland anticipate that this purchase order for HIV Self-Tests will be the first of many and are currently working to rapidly conclude a comprehensive agreement for supply of Atomo's award-winning HIV products to Newfoundland for Europe.